INTERVIEW 🎙️ Sa’ad Shah of Noetic Fund discusses Psychedelics, Drug Development & Pharma Delivery
Channel: Beryl Elites
Date: 2022-07-27

🔔 Hit SUBSCRIBE button and be the first to get new videos 🎬 Stay tuned on upcoming 120 unique new educational videos covering various aspects of financial markets and artificial intelligence. Join us on this journey of knowledge and innovation at the BERYL ELITES conference!

🗓️ Save the date for the BERYL ELITES 6th Annual Alternative Investments conference, happening in NYC on Oct 28-29. Immerse yourself in 18 dynamic panels featuring 85 esteemed speakers from top financial, investment, and technology companies.

Interview featuring:
Sa’ad Shah, Managing Partner, Noetic Fund
Andrew Lazarus, The Beryl Consulting Group

Interview Topics:
 What exactly is Noetic investing in and why should an investor consider Noetic
 Golden Era for Neuroscience – why should look at Mental Health
 Brain as the most complex Organism in the entire Universe
 What has been learned in the past 5 years, how are psychedelics different from cannabis?
 Pandemic and huge impact on Mental Health – no longer a taboo subject
 FDA recognized Psychedelics and efficacy of some of its compounds
 The market is still relatively small, $5 bn market cap – great opportunity 
 Psychedelics - Drug Development. Pharma delivery approach vs Recreation approach, What is the future of the psychedelics industry?

Beryl Elites Global Investments & Innovations Conferences encompass traditional institutional finance, alternative investments, fintech, alternative data, digital assets, and geopolitics. It features high-octane discussions, networking and entertainment in congenial ambiance. 

Visit the Beryl Elites Knowledge Center at berylelites.com/bkc for more primary sources and Beryl-ROI Curated Industry News at https://berylelites.com/beryl-roi-news 

Copyright 2024 The Beryl Consulting Group. All Rights Reserved.